Friday, September 30, 2022



Contact us 561.316.3330



Expansion of Partnership Between Paragonix and the Lung Transplant Foundation To Accelerate Commercialization of Innovative Lung Preservation Technlogies

Paragonix is currently completing commercial development of the Paragonix SherpaLung™ Preservation System and expects the filing of FDA pre-market notification and European CE clearance by Q4 2019. The Paragonix SherpaLung™ Preservation System is designed to ensure optimal lung preservation during its journey from donor to recipient patient by incorporating medically proven and clinically validated preservation techniques combined with lung inflation pressure control, ensuring stable inflation pressure on the ground or during air transport.

Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System to be Announced by Eyenuk Inc. at the ARVO...

Eyenuk Inc. will showcase its EyeArt® AI Eye Screening System for autonomous detection of DR at Booth #1637 at the Vancouver Convention Centre Exhibition Hall. In addition, key management team members will be available to meet with researchers, clinicians and potential industry partners during the ARVO annual meeting.

Huawei Launch Track AI to Help Detect Early Signs of Visual Impairment in Children Across the World

4/18/19: Huawei AI and smartphone technology to be used in eye hospitals around the world in partnership with leading eye institute.

ViewRay Partners with Device Technologies Australia Pty Ltd.

ViewRay, Inc. will partner with the largest independent distributor in Australasia, who will market, sell, and support ViewRay's MRIdian MRI-guided radiation therapy system.

By using this website you agree to accept Medical Device News Magazine Privacy Policy